
Paras Healthcare’s IPO is scheduled to open for subscription on October 21, 2026. According to its Red Herring Prospectus (RHP), the ₹1,450.00 crore issue comprises a fresh issue of 72.15 lakh equity shares worth up to ₹500.00 crore and an offer for sale (OFS) of 1.37 crore equity shares aggregating up to ₹950.00 crore.
The IPO will close on October 23, 2026. Allotment is expected on October 26, 2026, followed by listing on the BSE and NSE on October 28, 2026.
The expected IPO schedule is as follows:
|
Event |
Date |
|
Subscription Opening Date |
21 October 2026 |
|
Subscription Closing Date |
23 October 2026 |
|
Basis of Allotment Date |
26 October 2026 |
|
Refund Initiation Date |
27 October 2026 |
|
Credit of Shares |
27 October 2026 |
|
Listing on BSE and NSE |
28 October 2026 |
Note: The allotment and listing dates are tentative and may be revised.
Explore other Upcoming IPOs on BSE and NSE.
The application size for each category is as follows -
|
Category |
Investment Range |
|---|---|
|
Qualified Institutional Buyers (QIBs) |
Not more than 75% of the Net Issue |
|
Non-Institutional Investors (NIIs) |
Not less than 15% of the Net Issue |
|
Retail Individual Investors (RII) |
Not less than 10% of the Net Issue |
The minimum investment amount for each category, based on the upper price band of ₹693 per share, is as follows -
|
Investor Category |
Lots |
Shares |
Investment Amount (Approx.) |
|
Retail (Minimum) |
1 |
21 |
₹14,553 |
|
Retail (Maximum) |
13 |
273 |
₹1,89,189 |
|
sNII (Minimum) |
14 |
294 |
₹2,03,742 |
|
bNII (Minimum) |
69 |
1449 |
₹10,04,157 |
The company intends to utilise the net proceeds from the fresh issue towards:
Incorporated in 1987, Paras Healthcare Limited is a healthcare provider operating eight hospitals with a combined capacity of 2,211 beds across North India, Bihar and Jharkhand, under the “Paras Health” brand. As of June 30, 2026, its network spanned five states and one union territory.
The company plans to add 300 beds in Gurugram by Fiscal 2027 and 500 beds in Ludhiana by Fiscal 2028, taking its total capacity to 3,011 beds by March 2028. Its key specialties include cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and renal sciences, which contributed 74.70% of revenue in Fiscal 2026. The company had 1,084 doctors and 1,937 nurses as of June 30, 2026.
|
Particulars |
For the three month period ended June 30, 2026 (in ₹ crore) |
FY26 (in ₹ crore) |
FY25 (in ₹ crore) |
|
Revenue from operations |
470.28 |
1,605.95 |
1,294.06 |
|
EBITDA |
113.48 |
335.58 |
156.46 |
|
Profit After Tax (PAT) |
49.68 |
43.83 |
(57.98) |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here